Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027960 (
mole
)
21,279
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The rate of isomerization of alpha acids to iso-alpha acids (the compounds contributing
bitter taste
to beer) was determined across a range of temperatures (90-130 degrees C) to characterize the rate at which iso-alpha acids are formed during kettle boiling. Multiple 12 mL stainless steel vessels were utilized to heat samples (alpha acids in a pH 5.2 buffered aqueous solution) at given temperatures, for varying lengths of time. Concentrations of alpha acids and iso-alpha acids were quantified by high-pressure liquid chromatography (HPLC). The isomerization reaction was found to be first order, with reaction rate varying as a function of temperature. Rate constants were experimentally determined to be k1 = (7.9 x 10(11)) e(-11858/T) for the isomerization reaction of alpha acids to iso-alpha acids, and k2 = (4.1 x 10(12)) e(-12994/T) for the subsequent loss of iso-alpha acids to uncharacterized degradation products. Activation energy was experimentally determined to be 98.6 kJ per
mole
for isomerization, and 108.0 kJ per
mole
for degradation. Losses of iso-alpha acids to degradation products were pronounced for cases in which boiling was continued beyond two half-lives of alpha-acid concentration.
...
PMID:Isomerization and degradation kinetics of hop (Humulus lupulus) acids in a model wort-boiling system. 1591 6
Mexiletine hydrochloride is an orally active class I antiarrythmic agent. An extemporaneous solution of mexiletine hydrochloride was prepared for this study. Water was chosen as the vehicle due to the high solubility of the drug in water. Sorbitol, simple syrup and raspberry syrup were used as sweeteners in an attempt to mask the
bitter taste
of the drug. The solution was analyzed over 91 days of storage at five temperatures, ie, 4, 30, 40, 50 and 60 deg C.The sample was analyzed at 2, 6, 24, and 48 hours and the at 7, 14, 21, 28, 35, 42, 49, 56, 63, 70, 77, 84 and 91 days at each designated temperature. The peak area for the mexiletine hydrchloride peak at time t=0 was taken as 100%; and, accordingly the percentages of intact drug remaining at each interval were calculated. The log percentage of the drug remaining was lotted agaisnst time (in days) at each temperature. The first-order constants for mexiletine hydrochloride at 4, 30, 40, 50, and 60 deg C were calculated to be -0.0007, -0.0009, -0.0010. -0.0011 and -0.0013, respectively. The Arrhenius plot was obtained by plotting the first-order degradation constants against the reciprocal of the absolute temperatures. The first-order degradation constant for mexiletine hydrochloride at 25 deg C was found to be 9.053 x 10-4(day-1). The energy of activation for the reaction was calculated to be -8663.88 J/
mole
. The shelf lives of the formmulation at 4 and 25 deg C were found to be 173.3 and 115.5 days, respectively. An attempt was made to identify and characterize any degradation products using the high-performance liquid chromatographic-mass spectrometry technique, as none of the degradation products were detected by ultraviolet analysis. However, this attempt was unsuccessful due to coating of the injection port with the sample, which might be due to crystallization of any of the excipients of the formulation under high temperatures. A degradation mechanism has been hypothesized based on either acid or base attack on the parent compound. The products from this degradation are presented.
...
PMID:Extemporaneous formulation and stability testing of mexiletine hydrochloride solution. 2392 25